A critical appraisal of the quality of critical care pharmacotherapy clinical practice guidelines and their strength of recommendations

被引:20
|
作者
Gorman, Sean K. [1 ]
Chung, Michelle Ho [2 ]
Slavik, Richard S. [3 ]
Zed, Peter J. [1 ,4 ]
Wilbur, Kerry [5 ]
Dhingra, Vinay K. [6 ,7 ]
机构
[1] Dalhousie Univ, Dept Pharm, Coll Pharm, Capital Dist Hlth Author, C-O Rm 2043 Victoria Bldg,1276 S Pk St, Halifax, NS B3H 2Y9, Canada
[2] St Pauls Hosp, Dept Pharm, Vancouver, BC V6Z 1Y6, Canada
[3] Univ British Columbia, Dept Pharm, Interior Hlth Author, Fac Pharmaceut Sci, Kelowna, BC V1Y 3H5, Canada
[4] Dalhousie Univ, Dept Emergency Med, Halifax Infirm, Halifax, NS B3H 3A7, Canada
[5] Qatar Univ, Coll Pharm, Doha, Qatar
[6] Vancouver Gen Hosp, Intens Care Unit, Vancouver, BC V5Z 1M9, Canada
[7] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada
关键词
Clinical practice guideline; Critical appraisal; Quality of evidence; Critical care; Pharmacotherapy; CONSENSUS CONFERENCE; MANAGEMENT; ILL; THERAPY;
D O I
10.1007/s00134-010-1786-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Clinical practice guideline (CPG) quality assessment is important before applying their recommendations. Determining whether recommendation strength is consistent with supporting quality of evidence is also essential. We aimed to determine quality of critical care pharmacotherapy CPGs and to assess whether high quality evidence supports strong pharmacotherapy recommendations. MEDLINE (1966-February 2008), EMBASE (1980-February 2008), National Guideline Clearinghouse (February 2008) and personal files were searched to identify CPGs. Four appraisers evaluated each guideline using the appraisal of guidelines, research and evaluation (AGREE) instrument. AGREE assesses 23 items in six domains that include scope/purpose, stakeholder involvement, rigor of development, clarity, applicability and editorial independence. Standardized domain scores (0-100%) were determined to decide whether to recommend a guideline for use. One appraiser extracted strong pharmacotherapy recommendations and supporting evidence quality. Twenty-four CPGs were included. Standardized domain scores were clarity [69% (95% confidence interval (CI) 62-76%)], scope/purpose [62% (95% CI 55-68%)], rigor of development [51% (95% CI 42-60%)], editorial independence [39% (95% CI 26-52%)], stakeholder involvement [32% (95% CI 26-37%)] and applicability [19% (95% CI 12-26%)]. The proportion of guidelines that could be strongly recommended, recommended with alterations and not recommended was 25, 37.5 and 37.5%, respectively. High quality evidence supported 36% of strong pharmacotherapy recommendations. Variation in AGREE domain scores explain why one-third of critical care pharmacotherapy CPGs cannot be recommended. Only one-third of strong pharmacotherapy recommendations were supported by high quality evidence. We recommend appraisal of guideline quality and the caliber of supporting evidence prior to applying recommendations.
引用
收藏
页码:1636 / 1643
页数:8
相关论文
共 50 条
  • [1] A critical appraisal of the quality of critical care pharmacotherapy clinical practice guidelines and their strength of recommendations
    Sean K. Gorman
    Michelle Ho Chung
    Richard S. Slavik
    Peter J. Zed
    Kerry Wilbur
    Vinay K. Dhingra
    Intensive Care Medicine, 2010, 36 : 1636 - 1643
  • [2] Erratum to: A critical appraisal of the quality of critical care pharmacotherapy clinical practice guidelines and their strength of recommendations
    Sean K. Gorman
    Michelle Ho Chung
    Richard S. Slavik
    Peter J. Zed
    Kerry Wilbur
    Vinay K. Dhingra
    Intensive Care Medicine, 2010, 36 (10) : 1798 - 1801
  • [3] Quality of critical care clinical practice guidelines involving pharmacotherapy recommendations
    Edwards, Christopher
    Lam, Jonathan
    Gardiner, Jordan
    Erstad, Brian L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (21) : 1919 - 1924
  • [4] A Critical Appraisal and Comparison of the Quality and Recommendations of Glaucoma Clinical Practice Guidelines
    Ou, Yvonne
    Goldberg, Ivan
    Migdal, Clive
    Lee, Paul P.
    OPHTHALMOLOGY, 2011, 118 (06) : 1017 - 1023
  • [5] Clinical practice guidelines in primary health care: A critical appraisal
    Pantoja, Tomas
    Strain, Heather
    Valenzuela, Lorena
    REVISTA MEDICA DE CHILE, 2007, 135 (10) : 1282 - 1290
  • [6] Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis
    Xie, Xiuli
    Wang, Yangyang
    Yao, Sha
    Xia, Yun
    Luo, Hao
    Li, Lui
    Lu, Chuanjian
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2038 - 2050
  • [7] Clinical Practice Guidelines: Critical Appraisal is the Key
    Slavik, Richard
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 (04): : 223 - 225
  • [8] A critical appraisal of clinical practice guidelines for in the cord
    Guan, Bin
    Li, Guoyu
    Zheng, Ruiyuan
    Fan, Yuxuan
    Yao, Liang
    Chen, Lingxiao
    Feng, Shiqing
    Zhou, Hengxing
    SPINE JOURNAL, 2023, 23 (08): : 1189 - 1198
  • [9] Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis
    Ye, Zhi-Kang
    Liu, Ying
    Cui, Xiang-Li
    Liu, Li-Hong
    PLOS ONE, 2016, 11 (05):
  • [10] Clinical practice guidelines for prostate cancer: A critical appraisal of methodological quality
    Yeung, Lawrence L.
    Fesperman, Susan F.
    Algood, Chester B.
    Rosser, Charles J.
    Vieweg, Johannes
    Dahm, Philipp
    JOURNAL OF UROLOGY, 2008, 179 (04): : 8 - 8